Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing NaN - NaN of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Explore Clinical Characteristics of T1 Non-small Cell Lung

Completed
  • Non Small Cell Lung Cancer
  • Surgeries
  • Beijing, Beijing, China
  • +9 more
May 18, 2018

Explore Prognoses of NSCLC Patients Complicated With

Unknown status
  • Non Small Cell Lung Cancer
  • Surgeries
  • Beijing, Beijing, China
  • +9 more
Feb 7, 2018

Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Berkeley, California
  • +152 more
Jan 24, 2018

Breast Cancer, Prostate Cancer, Non Small Cell Lung Cancer Trial in Shanghai (Stereotactic Body Radiation Therapy)

Recruiting
  • Breast Cancer
  • +2 more
  • Stereotactic Body Radiation Therapy
  • Shanghai, Shanghai, China
    Department of Radiation Oncology,Renji Hospital affiliated to Sh
Jan 1, 2018

Non Small Cell Lung Cancer Trial in Shanghai (erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 11, 2017

Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Etoposide)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Birmingham, Alabama
  • +132 more
May 20, 2016

Non Small Cell Lung Cancer Trial in Shanghai (docetaxel, pemetrexed, Erlotinib)

Unknown status
  • Non Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Cancer hospital Fudan University
Feb 22, 2016

Non Small Cell Lung Cancer Trial in Shanghai (ABX Combined With Cisplatin, Gemcitabine Combined With Cisplatin)

Completed
  • Non Small Cell Lung Cancer
  • ABX Combined With Cisplatin
  • Gemcitabine Combined With Cisplatin
  • Shanghai, Shanghai, China
    Cancer hospital Fudan University
Feb 22, 2016

Non Small Cell Lung Cancer Trial in Shanghai (chemo followed dendritic cells, pemetrexed and carboplatin)

Unknown status
  • Non Small Cell Lung Cancer
  • chemotherapy followed dendritic cells
  • pemetrexed and carboplatin
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Jan 28, 2016

T790M Mutation Positive 2nd Line STandard of cAre Registry

Withdrawn
  • Non Small Cell Lung Cancer
    • Kentucky, Kentucky
    • +49 more
    Jul 6, 2015

    Non Small Cell Lung Cancer Trial in China (Pemetrexed, Gemcitabine, Cisplatin)

    Completed
    Has Results
    • Non Small Cell Lung Cancer
    • Beijing, China
    • +7 more
    Oct 18, 2013

    Non Small Cell Lung Cancer Trial in China (Pemetrexed (Alimta), Gefitinib (IRESSA))

    Completed
    • Non Small Cell Lung Cancer
    • Pemetrexed (Alimta)
    • Gefitinib (IRESSA)
    • Guangzhou, Guangdong, China
    • +6 more
    Dec 7, 2012

    Non Small Cell Lung Cancer Trial in Worldwide (Testing for mutation status)

    Completed
    • Non Small Cell Lung Cancer
    • Testing for mutation status
    • Beijing, Beijing, China
    • +35 more
    Aug 5, 2011

    Non Small Cell Lung Cancer Trial in Shanghai (Gemcitabine, Best supportive care)

    Unknown status
    • Non Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital Medical Oncology Department
    Apr 13, 2011